{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:09:59Z","timestamp":1778540999696,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Humanidades, Ciencias y Tecnolog\u00edas","doi-asserted-by":"publisher","award":["F003\/154039\/2019"],"award-info":[{"award-number":["F003\/154039\/2019"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006087","name":"UNAM DGAPA","doi-asserted-by":"publisher","award":["IN205023"],"award-info":[{"award-number":["IN205023"]}],"id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejphar.2025.177655","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T02:35:02Z","timestamp":1744943702000},"page":"177655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A positive allosteric modulator of \u03b17 nicotinic receptor reduces levodopa-induced dyskinesias in hemi-parkinsonian mice"],"prefix":"10.1016","volume":"998","author":[{"given":"Alejandra","family":"G\u00f3mez-Paz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4376-6677","authenticated-orcid":false,"given":"Vladimir","family":"Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8610-1691","authenticated-orcid":false,"given":"Aldo","family":"Luna-Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Palomero-Rivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Bargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejphar.2025.177655_bib1","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/ejn.13949","article-title":"Cholinergic modulation of striatal microcircuits","volume":"49","author":"Abudukeyoumu","year":"2018","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177655_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors. From structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2025.177655_bib3","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1172\/JCI90132","article-title":"Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy","volume":"127","author":"Alcacer","year":"2017","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177655_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/brainsci14030290","article-title":"The \u03b1-7 nicotinic receptor positive allosteric modulator alleviates lipopolysaccharide induced depressive-like behavior by regulating microglial function, trophic factor, and chloride transporters in mice","volume":"14","author":"Alzarea","year":"2024","journal-title":"Brain Sci."},{"issue":"8","key":"10.1016\/j.ejphar.2025.177655_bib5","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/ejn.15135","article-title":"Striatal cholinergic transmission. Focus on nicotinic receptors' influence in striatal circuits","volume":"53","author":"Assous","year":"2021","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177655_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejphar.2025.177655_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuroscience.2022.03.036","article-title":"Striatal neuronal ensembles reveal differential actions of amantadine and clozapine to ameliorate mice L-DOPA-Induced dyskinesia","volume":"492","author":"Calder\u00f3n","year":"2022","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2025.177655_bib8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuropharm.2012.10.019","article-title":"Positive allosteric modulator of \u03b17 nicotinic-acetylcholine receptors, PNU-120596 augments the effects of donepezil on learning and memory in aged rodents and non-human Primates","volume":"67","author":"Callahan","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2025.177655_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105930","article-title":"Selective activation of striatal indirect pathway suppresses levodopa induced - dyskinesias","volume":"176","author":"Castela","year":"2023","journal-title":"Neurobiol. Dis."},{"issue":"Suppl. 3","key":"10.1016\/j.ejphar.2025.177655_bib10","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1016\/S1353-8020(08)70014-2","article-title":"L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment","volume":"13","author":"Cenci","year":"2007","journal-title":"Parkinsonism Relat. Disorders"},{"key":"10.1016\/j.ejphar.2025.177655_bib11","article-title":"Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice","volume":"9","author":"Cenci","year":"2007","journal-title":"Curr Protoc Neurosci Chapter"},{"issue":"6","key":"10.1016\/j.ejphar.2025.177655_bib12","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/mds.27337","article-title":"Animal models of l-dopa-induced dyskinesia in Parkinson's disease","volume":"33","author":"Cenci","year":"2018","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177655_bib13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2025.177655_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nature12354","article-title":"Ultrasensitive fluorescent proteins for imaging neuronal activity","volume":"499","author":"Chen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177655_bib15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.biopsych.2009.04.025","article-title":"Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation","volume":"66","author":"Darmopil","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.177655_bib16","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1073\/pnas.1006511108","article-title":"Enhanced striatal cholinergic neuronal activity mediates L-DOPA induced dyskinesia in parkinsonian mice","volume":"108","author":"Ding","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.ejphar.2025.177655_bib17","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1523\/JNEUROSCI.19-09-03629.1999","article-title":"Cholinergic modulation of neostriatal output: a functional antagonism between different types of muscarinic receptors","volume":"19","author":"Galarraga","year":"1999","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.ejphar.2025.177655_bib18","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2174\/1871527311201070897","article-title":"Is nicotine protective against Parkinson's disease? An experimental analysis","volume":"11","author":"Garc\u00eda-Montes","year":"2012","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"issue":"6","key":"10.1016\/j.ejphar.2025.177655_bib19","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1007\/s12035-018-1356-6","article-title":"Genetic knockdown of mGluR5 in striatal D1R-Containing neurons attenuates L-DOPA-Induced dyskinesia in aphakia mice","volume":"56","author":"Garc\u00eda-Montes","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177655_bib20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.neuron.2018.01.017","article-title":"A subpopulation of striatal neurons mediates levodopa-induced dyskinesia","volume":"97","author":"Girasole","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2025.177655_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112776","article-title":"The \u03b17 nAChR allosteric modulator PNU-120596 amends neuroinflammatory and motor consequences of parkinsonism in rats: role of JAK2\/NF-\u03baB\/GSk3\u03b2\/TNF-\u03b1 pathway","volume":"148","author":"Gowayed","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.177655_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/943159","article-title":"Clinical features, pathophysiology, and treatment of levodopa-induced dyskinesias in Parkinson's disease","author":"Guridi","year":"2012","journal-title":"Parkinson Dis"},{"issue":"4","key":"10.1016\/j.ejphar.2025.177655_bib23","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/mds.26947","article-title":"Striatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease","volume":"32","author":"Hern\u00e1ndez","year":"2017","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177655_bib24","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/jnc.12751","article-title":"Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions","volume":"130","author":"Heumann","year":"2014","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177655_bib25","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1124\/jpet.111.182949","article-title":"Nicotine reduces L-DOPA-induced dyskinesias by acting at beta2\u2217 nicotinic receptors","volume":"338","author":"Huang","year":"2011","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177655_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/pr.111.005678","article-title":"The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease","volume":"65","author":"Huot","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2025.177655_bib27","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1111\/bph.14663","article-title":"Optostimulation of striatonigral terminals in substantia nigra induces dyskinesia that increases after L-DOPA in a mouse model of Parkinson's disease","volume":"176","author":"Keifman","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177655_bib28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mds.26082","article-title":"Levodopa therapy for Parkinson's disease: pharmacokinetics and pharmacodynamics","volume":"30","author":"LeWitt","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2025.177655_bib29","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s12264-023-01054-5","article-title":"The dynamics of dopamine D2 receptor expressing striatal neurons and the downstream circuit underlying L-Dopa-Induced dyskinesia in rats","volume":"39","author":"Liu","year":"2023","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.ejphar.2025.177655_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2022.945816","article-title":"Synaptic determinants of cholinergic interneurons hyperactivity during parkinsonism","volume":"14","author":"Padilla-Orozco","year":"2022","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.ejphar.2025.177655_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176573","article-title":"Angiotensin-converting enzyme inhibition prevents l-dopa-induced dyskinesia in a 6-ohda-induced mouse model of Parkinson's disease","volume":"973","author":"Park","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177655_bib32","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/mds.26955","article-title":"Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice","volume":"32","author":"Perez","year":"2017","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177655_bib33","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.neuroscience.2008.06.047","article-title":"Muscarinic M1 modulation of N and L types of calcium channels is mediated by protein kinase C in neostriatal neurons","volume":"155","author":"Perez-Burgos","year":"2008","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177655_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuroscience.2009.10.056","article-title":"CAV2.1 channels are modulated by muscarinic M1 receptors through phosphoinositide hydrolysis in neostriatal neurons","volume":"165","author":"P\u00e9rez-Burgos","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2025.177655_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/472676","article-title":"KV7 channels regulate firing during synaptic integration in GABAergic striatal neurons","volume":"2015","author":"P\u00e9rez-Ram\u00edrez","year":"2015","journal-title":"Neural Plast."},{"key":"10.1016\/j.ejphar.2025.177655_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.nbd.2016.02.023","article-title":"Pathophysiological signatures of functional connectomics in parkinsonian and dyskinetic striatal microcircuits","volume":"91","author":"P\u00e9rez-Ortega","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177655_bib37","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1152\/jn.00853.2004","article-title":"Cholinergic control of firing pattern and neurotransmission in rat neostriatal projection neurons: role of CAV2.1 and CAV2.2 CA2+ channels","volume":"93","author":"P\u00e9rez\u2010Rosello","year":"2005","journal-title":"J. Neurophysiol."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177655_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/ejn.70063","article-title":"\u03b17-Nicotinic acetylcholine receptor and mutated \u03b1-Synuclein interact in motor behaviour and nigrostriatal dopamine-findings with potential relevance for a protective effect of cigarette smoking and Parkinson's disease","volume":"61","author":"Pifl","year":"2025","journal-title":"Eur. J. Neurosci."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177655_bib39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tins.2007.07.008","article-title":"Re-emergence of striatal cholinergic interneurons in movement disorders","volume":"30","author":"Pisani","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2025.177655_bib40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fnsys.2013.00078","article-title":"Global actions of nicotine on the striatal microcircuit","volume":"7","author":"Plata","year":"2013","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177655_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"6","key":"10.1016\/j.ejphar.2025.177655_bib42","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ana.21203","article-title":"Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys","volume":"62","author":"Quik","year":"2007","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177655_bib43","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.neuropharm.2012.04.029","article-title":"Role for \u03b16 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian mice","volume":"63","author":"Quik","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2025.177655_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.brainres.2012.03.064","article-title":"Positive allosteric modulation of \u03b14\u03b22 nAChR agonist induced behaviour","volume":"1458","author":"Rode","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2025.177655_bib45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jchemneu.2017.08.002","article-title":"Parvalbumin, but not calretinin, neurons express high levels of \u03b11-containing GABAA receptors, \u03b17-containing nicotinic acetylcholine receptors and D2-dopamine receptors in the basolateral amygdala of the rat","volume":"86","author":"R\u00f3wniak","year":"2017","journal-title":"J. Chem. Neuroanat."},{"issue":"12","key":"10.1016\/j.ejphar.2025.177655_bib46","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1016\/j.celrep.2018.05.059","article-title":"Aberrant striatal activity in parkinsonism and levodopa-induced dyskinesia","volume":"23","author":"Ryan","year":"2018","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.ejphar.2025.177655_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114483","article-title":"Excessive firing of dyskinesia-associated striatal direct pathway neurons is gated by dopamine and excitatory synaptic input","volume":"43","author":"Ryan","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2025.177655_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fncir.2018.00057","article-title":"Hyperactive response of direct pathway striatal projection neurons to L-dopa and D1 agonism in freely moving parkinsonian mice","volume":"12","author":"Sagot","year":"2018","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.ejphar.2025.177655_bib49","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.nbd.2016.09.001","article-title":"Validation of an improved scale for rating l-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists","volume":"96","author":"Sebastianutto","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2025.177655_bib50","article-title":"Bidirectional regulation of levodopa-induced dyskinesia by a specific neural ensemble in globus pallidus external segment","volume":"8","author":"Shen","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ejphar.2025.177655_bib51","article-title":"To deconvolve, or not to deconvolve: inferences of neuronal activities using calcium imaging data","volume":"15","author":"Shen","year":"2022","journal-title":"J. Neurosci. Methods"},{"issue":"32","key":"10.1016\/j.ejphar.2025.177655_bib52","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1523\/JNEUROSCI.1381-05.2005","article-title":"Cholinergic suppression of KCNQ channel currents enhances excitability of striatal medium spiny neurons","volume":"25","author":"Shen","year":"2005","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.ejphar.2025.177655_bib53","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/nn1972","article-title":"Cholinergic modulation of KIR2 channels selectively elevates dendritic excitability in striatopallidal neurons","volume":"10","author":"Shen","year":"2007","journal-title":"Nat. Neurosci."},{"issue":"9","key":"10.1016\/j.ejphar.2025.177655_bib54","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrd2927","article-title":"Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system","volume":"8","author":"Taly","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177655_bib55","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1476-5381.2012.01989.x","article-title":"Augmentation of cognitive function by NS9283, a stoichiometry-dependent positive allosteric modulator of \u03b12- and \u03b14-containing nicotinic acetylcholine receptors","volume":"167","author":"Timmermann","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177655_bib56","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuroscience.2013.07.032","article-title":"Active decorrelation in the basal ganglia","volume":"250","author":"Wilson","year":"2013","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177655_bib57","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/nbdi.2002.0499","article-title":"l-DOPA-Induced dyskinesia in the intrastriatal 6-Hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function","volume":"10","author":"Winkler","year":"2002","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177655_bib58","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/jpet.113.207639","article-title":"Nicotinic receptor agonists reduce L-DOPA-induced dyskinesias in a monkey model of Parkinson's disease","volume":"347","author":"Zhang","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177655_bib59","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/neu.10150","article-title":"Cholinergic interneuron characteristics and nicotinic properties in the striatum","volume":"53","author":"Zhou","year":"2002","journal-title":"J. Neurobiol."},{"issue":"8","key":"10.1016\/j.ejphar.2025.177655_bib60","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bcp.2011.05.007","article-title":"Potentiation of analgesic efficacy but not side effects: co-administration of an \u03b14\u03b22 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats","volume":"82","author":"Zhu","year":"2011","journal-title":"Biochem. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925004091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925004091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:31:08Z","timestamp":1762144268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925004091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":60,"alternative-id":["S0014299925004091"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177655","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A positive allosteric modulator of \u03b17 nicotinic receptor reduces levodopa-induced dyskinesias in hemi-parkinsonian mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177655"}}